Literature DB >> 26026739

Heart disease in pregnancy.

Y Emmanuel1, S A Thorne2.   

Abstract

Cardiac disease is the leading cause of maternal mortality in the developed world. The majority of women with heart disease are able to successfully undergo pregnancy. However, in women with severely impaired ventricular function, severe left heart obstruction, pulmonary hypertension and aortopathy, such as Marfan syndrome, with significant aortic dilatation, pregnancy is associated with a significant risk, and these women should be counselled against pregnancy if there is no option for treatment that reduces risk. Although there are increasing numbers of women with congenital heart disease who are considering pregnancy, as a result of joint expert specialist cardiac and obstetric care, maternal mortality is low. Most of the observed mortality occurs in women with structurally normal hearts who were not known to have heart disease before their pregnancy. It is therefore important that those caring for pregnant women are aware of the risk factors for and presentation of cardiac conditions in pregnancy. We review the presentation and management of both congenital and acquired heart diseases in pregnancy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  heart disease; pregnancy

Mesh:

Substances:

Year:  2015        PMID: 26026739     DOI: 10.1016/j.bpobgyn.2015.04.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  7 in total

1.  [Application of sevoflurane and laryngeal mask in cesarean section in women with heart disease].

Authors:  Zhi-Peng Wang; Jue Ma; Sheng Wang; Li-Na Yu; Jin-Feng Wei; Jin-Dong Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

2.  Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox database.

Authors:  Maria Hoeltzenbein; Marie-Louise Lehmann; Evelin Beck; Katarina Dathe; Christof Schaefer
Journal:  Eur J Clin Pharmacol       Date:  2021-01-26       Impact factor: 2.953

Review 3.  Heart Disease and Pregnancy.

Authors:  Reza Ashrafi; Stephanie L Curtis
Journal:  Cardiol Ther       Date:  2017-07-05

4.  Biomechanics of Human Fetal Hearts with Critical Aortic Stenosis.

Authors:  Chi Wei Ong; Meifeng Ren; Hadi Wiputra; Joy Mojumder; Wei Xuan Chan; Andreas Tulzer; Gerald Tulzer; Martin Lindsay Buist; Citra Nurfarah Zaini Mattar; Lik Chuan Lee; Choon Hwai Yap
Journal:  Ann Biomed Eng       Date:  2020-11-11       Impact factor: 3.934

Review 5.  Valvular heart disease in pregnancy.

Authors:  John Anthony; Ayesha Osman; Mahmoud U Sani
Journal:  Cardiovasc J Afr       Date:  2016 Mar-Apr       Impact factor: 1.167

Review 6.  Obstetric and offspring risks of women's morbid conditions linked to prior anticancer treatments.

Authors:  Juan J Tarín; Miguel A García-Pérez; Antonio Cano
Journal:  Reprod Biol Endocrinol       Date:  2016-07-07       Impact factor: 5.211

7.  Rheumatic Heart Disease among Pregnant Women with Cardiac Diseases in a Tertiary Care Center of Nepal: A Descriptive Cross-sectional Study.

Authors:  Basant Sharma; Eliza Koirala; Sudhir Regmi; Jaya Dhungana; Bandana Khanal Neupane; Suraj Bhattarai
Journal:  JNMA J Nepal Med Assoc       Date:  2021-05-25       Impact factor: 0.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.